The role of ubiquitination in tumorigenesis and targeted drug discovery
Ubiquitination, an important type of protein posttranslational modification (PTM), plays a
crucial role in controlling substrate degradation and subsequently mediates the “quantity” …
crucial role in controlling substrate degradation and subsequently mediates the “quantity” …
[HTML][HTML] Roles of F-box proteins in cancer
F-box proteins, which are the substrate-recognition subunits of SKP1–cullin 1–F-box protein
(SCF) E3 ligase complexes, have pivotal roles in multiple cellular processes through …
(SCF) E3 ligase complexes, have pivotal roles in multiple cellular processes through …
[HTML][HTML] SCF ubiquitin ligase-targeted therapies
The clinical successes of proteasome inhibitors for the treatment of cancer have highlighted
the therapeutic potential of targeting this protein degradation system. However, proteasome …
the therapeutic potential of targeting this protein degradation system. However, proteasome …
[HTML][HTML] EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains
MC Donaldson-Collier, S Sungalee, M Zufferey… - Nature …, 2019 - nature.com
Chromatin is organized into topologically associating domains (TADs) enriched in distinct
histone marks. In cancer, gain-of-function mutations in the gene encoding the enhancer of …
histone marks. In cancer, gain-of-function mutations in the gene encoding the enhancer of …
Degrons in cancer
Degrons are the elements that are used by E3 ubiquitin ligases to target proteins for
degradation. Most degrons are short linear motifs embedded within the sequences of …
degradation. Most degrons are short linear motifs embedded within the sequences of …
FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth
M Niu, J Xu, Y Liu, Y Li, T He, L Ding, Y He, Y Yi… - Nature …, 2021 - nature.com
Abnormal activation of epidermal growth factor receptor (EGFR) drives non-small cell lung
cancer (NSCLC) development. EGFR mutations-mediated resistance to tyrosine-kinase …
cancer (NSCLC) development. EGFR mutations-mediated resistance to tyrosine-kinase …
KrasG12D and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung
Y Maeda, T Tsuchiya, H Hao… - The Journal of …, 2012 - Am Soc Clin Investig
Mucinous adenocarcinoma of the lung is a subtype of highly invasive pulmonary tumors and
is associated with decreased or absent expression of the transcription factor NK2 homeobox …
is associated with decreased or absent expression of the transcription factor NK2 homeobox …
Emerging therapies targeting the ubiquitin proteasome system in cancer
NM Weathington, RK Mallampalli - The Journal of clinical …, 2014 - Am Soc Clin Investig
The ubiquitin proteasome system (UPS) is an essential metabolic constituent of cellular
physiology that tightly regulates cellular protein concentrations with specificity and precision …
physiology that tightly regulates cellular protein concentrations with specificity and precision …
[HTML][HTML] F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
DS Tekcham, D Chen, Y Liu, T Ling, Y Zhang… - Theranostics, 2020 - ncbi.nlm.nih.gov
E3 ubiquitin ligases play a critical role in cellular mechanisms and cancer progression. F-
box protein is the core component of the SKP1-cullin 1-F-box (SCF)-type E3 ubiquitin ligase …
box protein is the core component of the SKP1-cullin 1-F-box (SCF)-type E3 ubiquitin ligase …
[HTML][HTML] A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation
BB Chen, TA Coon, JR Glasser, BJ McVerry… - Nature …, 2013 - nature.com
Uncontrolled activation of tumor necrosis factor receptor–associated factor (TRAF) proteins
may result in profound tissue injury by linking surface signals to cytokine release. Here we …
may result in profound tissue injury by linking surface signals to cytokine release. Here we …